Publication | Closed Access

Immunologic Effect and Tolerability of Intra-Seasonal Subcutaneous Immunotherapy With an 8-Day Up-Dosing Schedule to 10,000 Standardized Quality-Units: A Double-Blind, Randomized, Placebo-Controlled Trial

Standardized Quality-unitsIntra-seasonal Subcutaneous ImmunotherapyAllergyImmunologyClinical TrialsVaccine TrialOral ImmunotherapyPlacebo-controlled TrialImmunotherapyMedicine